Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

C-reactive protein-mediated complement activation in polymyalgia rheumatica and other systemic inflammatory diseases

  • 27 Accesses

  • 4 Citations

Summary

An immunoglobulin-independent deposition of the complement (C) components C4 and C3 occurs on rat kidney medullary structures, when sera of patients with various inflammatory diseases are studied by indirect immunofluorescence. The diagnostic value of this new test (C4-C3-IFT) for polymyalgia rheumatica (PMR) is stressed, since all sera from patients with active disease yielded positive reactions. Though highly sensitive with respect to PMR, C4/C3-IFT is not specific for this syndrome. Examples of positive reactions in systemic inflammatory diseases other than PMR are documented. Besides the clinical studies, C4/C3-IFT reactivity was analyzed with regard to the mechanisms of the reaction. Experimental data are presented which suggest that C-reactive protein (CRP) binds to rat kidney structures, thereby activating the classical C cascade. As a result of CRP-C interaction, C4 and C3 components are fixed to distinct renal medullary structures. Because of its technical simplicity, C4/C3-IFT can routinely be used to screen patients' sera for CRP-mediated C activation. This ex vivo test system may contribute to a better understanding of pathophysiological functions of serum CRP in various inflammatory diseases.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Vaith P, Maas D, Stackelberg Gv, Peter HH (1986) A new serological reaction in patients with polymyalgia rheumatica and/or giant cell (temporal) arteritis: Deposition of complement C4 and C3 components on rat kidney structures detected by indirect immunofluorescence. Rheumatol Int 6:255–261

  2. 2.

    Tillet WS, Francis T (1930) Serological reactions in pneumonia with a nonprotein fraction from pneumococcus. J Exp Med 52:561

  3. 3.

    Morley JJ, Kushner I (1982) Serum C-reactive protein levels in disease. Ann NY Acad Sci 389:406–418

  4. 4.

    Claus DR, Osmand AP, and Gewurz H (1976) Radioimmunoassay of human C-reactive protein and levels in normal sera. J Lab Clin Med 87:120–128

  5. 5.

    Pepys MB, Baltz ML (1983) Acute phase proteins with special reference to C-reactive protein and related proteins (pentraxins) and serum amyloid A protein. Adv Immunol 34:141–212

  6. 6.

    Kushner I, Kaplan MH (1961) Studies of acute phase protein. I. An immunohistochemical method for the localization of Cx-reactive protein in rabbits. Association with necrosis in local inflammatory lesions. J Exp Med 114:961–973

  7. 7.

    Kushner I, Rakita L, Kaplan MH (1963) Studies of acutephase protein. II. Localization of Cx-reactive protein in heart in induced myocardial infarction in rabbits. J Clin Invest 42:286–292

  8. 8.

    Parish WE (1977) Features of human spontaneous vasculitis reproduced experimentally in animals. Effects of antiglobulins, C-reactive protein and fibrin. In: Bayer Symposium IV. Experimental models of chronic inflammatory diseases. Springer, Berlin Heidelberg New York, pp 117–151

  9. 9.

    Du Clos TW, Mold C, Paterson PY, Alroy J, Gewurz H (1981) Localization of C-reactive protein in inflammatory lesions of experimental allergic encephalomyelitis. Clin Exp Immunol 43:565–573

  10. 10.

    Kushner I (1984) Induction and control of acute phase reactant synthesis. In: Arnaud P, Bienvenu J, Laurent P (eds.) Marker proteins in inflammation, vol 2. de Gruyter, Berlin New York, pp 3–14

  11. 11.

    Gotschlich EC, Edelman GM (1985) C-reactive protein: a molecule composed of subunits. Proc Natl Acad Sci USA 54:558–566

  12. 12.

    Oliveira EB, Gotschlich EC, Liu TY (1979) Primary structure of human C-reactive protein. J Biol Chem 254:489–502

  13. 13.

    Gewurz H, Mold C, Siegel J, Fiedel B (1982) C-reactive protein and the acute phase response. Adv Int Med 27:345–372

  14. 14.

    Volanakis JE, Clements WL, Schrohenloher RE (1978) C-reactive protein purification by affinity chromatography and physicochemical characterization. J Immunol Methods 23:285–295

  15. 15.

    Osmand AP, Friedenson B, Gewurz H, Painter RH, Hofmann T, Shelton E (1977) Characterization of C-reactive protein and the complement component Clt as homologous proteins displaying cyclic pentameric symmetry (pentraxins). Proc Natl Acad Sci 74:739–743

  16. 16.

    Gotschlich EC, Edelman GM (1987) Binding properties and specificity of C-reactive protein. Proc Natl Acad Sci USA 57:706–712

  17. 17.

    Volanakis JE, Kaplan MH (1971) Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. Proc Soc Exp Biol Med 136:612–614

  18. 18.

    Heidelberger M, Gotschlich EC, Higginbotham JD (1972) Inhibition experiments with pneumococcal C and depyruvated type IV polysaccharides. Carbohydr Res 22:1–4

  19. 19.

    diCamelli R, Potempa LA, Siegel J, Suyehira L, Petras K, Gewurz H (1980) Binding reactivity of C-reactive protein for polycations. J Immunol 125:1933–1938

  20. 20.

    Robey FA, Jones KD, Tanaka T, Liu TY (1984) Binding of C-reactive protein to chromatin and nucleosome core particles. A possible physiological role of C-reactive protein. J Biol Chem 259:7311–7316

  21. 21.

    Salonen EM, Vartio T, Hedman K, Vaheri A (1984) Binding of fibronectin by the acute phase reactant C-reactive protein. J Biol Chem 259:1496–1501

  22. 22.

    Rowe IF, Soutar AK, Trayner IM, Thompson GR, Pepys MB (1984) Circulating human C-reactive protein binds very low density lipoproteins. Clin Exp Immunol 58:237–244

  23. 23.

    Kaplan MH, Volanakis JE (1974) Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. J Immunol 112:2135–2147

  24. 24.

    Siegel J, Osmand AP, Wilson MF, Gewurz H (1975) Interactions of C-reactive protein with the complement system. II. C-reactive protein-mediated consumption of complement by poly-l-lysine polymers and other polycations. J Exp Med 142:709–721

  25. 25.

    Claus DR, Siegel J, Petras K, Osmand AP, Gewurz H (1977) Interactions of C-reactive protein with the first component of human complement. J Immunol 119:187–192

  26. 26.

    Osmand AP, Mortensen RF, Siegel J, Gewurz H (1975) Interactions of C-reactive protein with the complement system. III. Complement-dependent passive hemolysis initiated by CRP. J Exp Med 142:1065–1077

  27. 27.

    Richards RL, Gewurz H, Osmand AP, Alving CR (1977) Interactions of C-reactive protein and complement with liposomes. Proc Natl Acad Sci USA 74:5672–5676

  28. 28.

    Mayer M (1961). In: Kabat EA, Mayer M (eds) Experimental immunochemistry, 2nd edn. Thomas, Springfield, Ill, pp 133–240

  29. 29.

    Maas D and Schubothe H (1973). Ein Lupus erythematodes-ähnliches Syndrom mit antimitochondrialen Antikörpern. Dtsch Med Wochenschr 98:131–139

  30. 30.

    Vogt W (1974) Activation, activities and pharmacologically active products of complement. Pharmacol Rev 26:125–169

  31. 31.

    Donaldson VH (1968) Mechanisms of activation of C1 esterase in hereditary angioneurotic edema plasma in vitro. J Exp Med 127:411–429

  32. 32.

    Volanakis JE (1982) Complement-induced solubilization of C-reactive protein-pneumococcal C-polysacchardie precipitates: Evidence for covalent binding of complement proteins to C-reactive protein and to pneumococcal C-polysaccharide. J Immunol 128:2745–2750

  33. 33.

    Robey FA, Jones KD, Steinberg AD (1985) C-reactive protein mediates the solubilization of nuclear DNA by complement in vitro. J Exp Med 161:1344–1356

  34. 34.

    Potempa LA, Siegel JN, Gewurz H (1981) Binding reactivity of C-reactive protein for polycations. II. Modulatory effects of calcium and phosphocholine. J Immunol 127:1509–1514

Download references

Author information

Additional information

This paper is dedicated to Prof. Dr. Dr. G. W. Löhr on the occasion of his 65th birthday

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Vaith, P., Hänsch, G.M. & Peter, H.H. C-reactive protein-mediated complement activation in polymyalgia rheumatica and other systemic inflammatory diseases. Rheumatol Int 8, 71–80 (1988). https://doi.org/10.1007/BF00271838

Download citation

Key words

  • C-reactive protein
  • Complement components C4 and C3
  • Polymyalgia rheumatica